35 results on '"Baglin, T"'
Search Results
2. Cryoprecipitate: an outmoded treatment?
3. The potential role of synovial thrombomodulin in the pathophysiology of joint bleeds in haemophilia
4. Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A
5. Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery
6. Pharmacokinetics of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A
7. A reversible defect of platelet PDGF content in myeloproliferative disorders
8. Therapy-related leukaemia in Wegener's granulomatosis
9. Intra-ocular haemorrhage, a frequent complication of acute promyelocytic leukaemia
10. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence
11. Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency
12. Severe factor X deficiency due to a homozygous mutation (Cys364Arg) that disrupts a disulphide bond in the catalytic domain
13. Platelet size has diagnostic predictive value in patients with thrombocytopenia
14. Travellers’ thrombosis and economy class syndrome: incidence, aetiology and prevention
15. Bacterial endocarditis in a child with haemophilia B: risks of central venous catheters
16. Which marker of myocardial long axis function is best for quantitating stress echo?
17. Is integrated backscatter a quantitative marker of ischemia during stress echo: Comparison with tissue doppler, wall motion and quantitative angiography
18. Comparison of long axis tissue doppler and systolic myocardial backscatter with stress — Do they offer complimentary information?
19. Is systolic myocardial doppler velocity response to stress influenced by loading conditions?
20. THE DIAGNOSIS and MANAGEMENT OF FACTOR VIII and IX INHIBITORS: A GUIDELINE FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANIZATION (UKHCDO)
21. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)
22. Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease
23. Solvent/detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura
24. A Randomized Trial of Solvent/Detergent and Standard Fresh Frozen Plasma in the Treatment of the Coagulopathy seen during Orthotopic Liver Transplantation
25. Thrombocytopenia following liver transplantation is associated with platelet consumption and thrombin generation
26. Guidelines on gamma irradiation of blood components for the prevention of transfusion‐associated graft‐versus‐host disease
27. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories
28. Quantitation of reticulated platelets: methodology and clinical application
29. Haemoglobin Dhofar is linked to the codon 29 C –→ T (IVS-1 nt – 3) splice mutation which causes /3+thalassaemia
30. Prevalence of serum IgG antibodies to hepatitis A virus in Cambridge haemophiliacs
31. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia
32. CAMPATH‐1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura
33. Transfusion-associated graft-versus-host disease in patients with Hodgkin's disease and T cell lymphoma
34. A reversible defect of platelet PDGF content in myeloproliferative disorders
35. CENTRAL VENOUS THROMBOSIS DUE TO BOLUS INJECTIONS OF ANTILEUKAEMIC CHEMOTHERAPY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.